Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Antidepressant holds promise in treating Alzheimer’s agitation

by Johns Hopkins Medicine
February 19, 2014
in Psychopharmacology
Share on TwitterShare on Facebook
Don't miss out! Follow PsyPost on Bluesky!

The antidepressant drug citalopram, sold under the brand names Celexa and Cipramil and also available as a generic medication, significantly relieved agitation in a group of patients with Alzheimer’s disease. In lower doses than those tested, the drug might be safer than antipsychotic drugs currently used to treat the condition, according to results of a clinical trial led by Johns Hopkins researchers that included seven other academic medical centers in the United States and Canada.

For the study, reported in the Feb. 19 issue of the Journal of the American Medical Association, Constantine Lyketsos, M.D., M.H.S., and his colleagues recruited 186 patients with Alzheimer’s who showed a collection of symptoms including emotional distress, excessive movement, aggression, disruptive irritability and disinhibition. None experienced adequate symptom relief with non-medical therapies, and some experienced failed treatment with antipsychotic drugs. Though antipsychotics are often used as first-line medications for Alzheimer’s-related agitation, they significantly increase the risk of strokes, heart attacks and death, Lyketsos says.

At the start of the study, patients also underwent tests to define the extent of their agitation, memory and other cognitive skills, and their caregivers’ stress levels, a factor strongly linked to the well-being of those with Alzheimer’s. The patients were then separated into two groups. For the next nine weeks, about half took increasing doses of citalopram that peaked at 30 milligrams per day, and the rest took an identical-looking placebo.

At the end of the study period, the same set of tests was given, along with electrocardiograms. The study drug is linked to adverse effects on heart function, including irregular heartbeat, a harbinger of a heart attack.

Results showed that patients on the drug had significant relief from their agitation symptoms, Lyketsos says. In one measure of agitation, about 40 percent of patients who took citalopram had “considerable relief,” compared to 26 percent of patients who took the placebo. The caregivers for these patients reported less stress.

However, patients on the drug were also more likely to have slightly decreased cognitive function. “It was not huge, but measureable,” says Lyketsos, director of the Johns Hopkins Memory and Alzheimer’s Treatment Center and director of the Department of Psychiatry at Johns Hopkins Bayview Medical Center. “That introduces a tradeoff.”

More concerning, he adds, is that patients on citalopram had longer QTc intervals, a measure of abnormal heart function that increases the risk of heart attacks. However, Lyketsos says, antipsychotic medications also used to treat agitation increase heart attack risk as well, perhaps even more substantially.

Lyketsos and his colleagues hope to test if a lower dose of citalopram might be just as effective in treating Alzheimer’s-related agitation with less risk for cognition and heart function. In the meantime, he says, the drug offers an alternative to antipsychotics.

“If the agitation is not responding to non-medication treatments and your patient’s agitation isn’t improving, there are no great options,” Lyketsos says. “But here’s another medication choice that might be safer than other medications and seems to be just as effective.”

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Bacteria in water, 3d illustration
Anxiety

Common antidepressants and anti-anxiety drugs tied to major shifts in gut microbiome composition

July 18, 2025

A surprising new study reveals a twist in the gut-brain connection. While anxiety and depression are linked to distinct gut bacteria, commonly prescribed medications show an even stronger association with microbiome changes than the mental health conditions themselves.

Read moreDetails
Stress-induced “fixated” eating patterns linked to dopamine disruption, study finds
Cannabis

Cannabis alternative 9(R)-HHC may be as potent as THC, study in mice suggests

July 17, 2025

A new study shows that only one form of hexahydrocannabinol—9(R)-HHC—produces behavioral effects similar to THC in mice, raising concerns about its psychoactive potential. The findings highlight key differences between HHC variants commonly sold as cannabis alternatives.

Read moreDetails
New study links honor cultures to higher rates of depression, suicidal thoughts
Depression

A single dose of lamotrigine causes subtle changes in emotional memory

July 17, 2025

A new study suggests that lamotrigine, a drug used to prevent bipolar depression, may influence how people recall emotional information. Healthy volunteers who took a single dose remembered more positive self-relevant words than negative ones, without reporting mood changes.

Read moreDetails
ADHD and brainwaves: How neuroscience is changing the way we diagnose the condition
Caffeine

Caffeine increases brain complexity during sleep, study shows

July 16, 2025

Think you can sleep fine after a late coffee? A new study suggests otherwise. Researchers found that while caffeine may not prevent sleep, it creates a "shallower" rest by increasing brain complexity and pushing it toward a more wake-like state.

Read moreDetails
New research sheds light on psychedelics’ complex relationship to psychosis and mania
Mental Health

Psychedelic retreats show promise in easing depression, PTSD, and reintegration struggles among veterans

July 16, 2025

Military veterans who attended psilocybin or ayahuasca retreats showed improvements in measures of depression, PTSD, anxiety, and reintegration into civilian life compared to their baseline assessments.

Read moreDetails
Female cannabis users have smaller volume of the cerebellum and poorer sleep quality, study finds
Cannabis

Medicinal cannabis may actually worsen sleep, a new study finds

July 16, 2025

While many people use cannabis to help them sleep, a new study reveals a surprising outcome. Researchers found a single dose of a medicinal cannabis oil actually decreased total sleep time and significantly suppressed the REM sleep (or dreaming) phase.

Read moreDetails
Caffeine use prevents stress-induced impairment of spatial memory
Caffeine

Caffeine may help prevent depression-like symptoms by protecting the gut-brain connection

July 15, 2025

Caffeine may help prevent stress-induced depression-like symptoms in mice by protecting gut health and reducing inflammation. While more research is needed, the findings raise the possibility that everyday dietary habits could play a meaningful role in mental health

Read moreDetails
Pills spilling out of a bottle on a table
ADHD

Methylphenidate: ADHD drug curbs impulsivity in men only, linked to brain wiring differences

July 13, 2025

Researchers found that methylphenidate lowers impulsive choice behavior in men but not women. The effect was associated with the structural integrity of specific white matter tracts in the brain, highlighting potential sex-based differences in drug response.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Key Alzheimer’s protein found at astonishingly high levels in healthy newborns

People’s ideal leader isn’t hyper-masculine — new study shows preference for androgynous traits

Chronic pain rewires how the brain processes punishment, new research suggests

Common antidepressants and anti-anxiety drugs tied to major shifts in gut microbiome composition

New psychology study: Inner reasons for seeking romance are a top predictor of finding it

Scientists demonstrate that “AI’s superhuman persuasiveness is already a reality”

Cannabis alternative 9(R)-HHC may be as potent as THC, study in mice suggests

A single dose of lamotrigine causes subtle changes in emotional memory

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy